Fresenius SE & Co KGaA (FRE) Given a €85.00 Price Target by Commerzbank Analysts

Fresenius SE & Co KGaA (FRA:FRE) has been given a €85.00 ($104.94) price objective by stock analysts at Commerzbank in a research note issued to investors on Friday, February 16th. The firm presently has a “buy” rating on the stock. Commerzbank’s price objective would suggest a potential upside of 32.69% from the company’s current price.

FRE has been the topic of several other research reports. Kepler Capital Markets set a €63.00 ($77.78) target price on shares of Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a research report on Tuesday, November 28th. Warburg Research set a €80.00 ($98.77) target price on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research report on Thursday, December 21st. UBS Group set a €59.00 ($72.84) target price on shares of Fresenius SE & Co KGaA and gave the stock a “sell” rating in a research report on Friday, January 5th. Citigroup set a €83.00 ($102.47) target price on shares of Fresenius SE & Co KGaA and gave the stock a “buy” rating in a research report on Monday, February 12th. Finally, Goldman Sachs Group set a €74.50 ($91.98) target price on shares of Fresenius SE & Co KGaA and gave the stock a “neutral” rating in a research report on Tuesday, January 30th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of €78.16 ($96.50).

Fresenius SE & Co KGaA (FRA:FRE) traded down €0.22 ($0.27) during trading hours on Friday, reaching €64.06 ($79.09). 1,223,704 shares of the company’s stock traded hands. The stock has a market cap of $35,540.00 and a P/E ratio of 20.87. Fresenius SE & Co KGaA has a 12 month low of €60.16 ($74.27) and a 12 month high of €80.00 ($98.77).

TRADEMARK VIOLATION NOTICE: This story was first posted by BBNS and is the property of of BBNS. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://baseballnewssource.com/2018/03/14/commerzbank-analysts-give-fresenius-se-85-00-price-target/1889977.html.

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Tampa Bay Starting Relievers In Place of Starters
Tampa Bay Starting Relievers In Place of Starters
Teen Juan Soto Hits Home Run in First At-Bat
Teen Juan Soto Hits Home Run in First At-Bat
Ji-Man Choi Receives Another Chance in Milwaukee
Ji-Man Choi Receives Another Chance in Milwaukee
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Strikeouts Once Again Plaguing Cubs
Strikeouts Once Again Plaguing Cubs
Atlanta Braves: A Mix of Young and Old
Atlanta Braves: A Mix of Young and Old


Leave a Reply

 
© 2006-2018 BBNS.